• Strategies for clinical development and marketing authorization for Biosimilars
• Module 2 CTD – Clinical & non-Clinical Overviews, Well Established Use
• Scientific & administrative support of regulatory queries, Expert Reports
• Type II Variations & Renewals
• Regulatory dossier compilation, evaluation & submission to IRBs